- Report
- February 2024
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- August 2023
- 97 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2023
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Book
- September 2024
- 224 Pages
- Book
- February 2014
- 356 Pages
Enzyme replacement therapy is a form of medical treatment that involves replacing a missing or deficient enzyme in the body with a synthetic version. This type of therapy is used to treat a variety of diseases, including lysosomal storage disorders, metabolic disorders, and some inherited diseases. Enzyme replacement therapy can be used to replace enzymes that are missing or deficient due to genetic mutations, or to supplement enzymes that are not functioning properly due to disease or injury.
The enzyme replacement market is a rapidly growing sector of the healthcare industry, with a focus on providing treatments for rare and inherited diseases. This market is driven by the increasing prevalence of rare diseases, the development of new treatments, and the increasing demand for personalized medicine. Companies in this market are focused on developing and commercializing enzyme replacement therapies, as well as providing support services to patients and healthcare providers.
Some of the major companies in the enzyme replacement market include Sanofi, Pfizer, Shire, Amicus Therapeutics, and Alexion Pharmaceuticals. Show Less Read more